Australia’s ambition to remain a globally competitive destination for clinical trials risks falling short unless investment in digital reform is matched by sustained investment in people, according to a new pre-Budget submission from ARCS Australia.
ARCS warns workforce gaps threaten returns on clinical trials reform
January 29, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
International HTA Collaboration continues as global pricing pressures evolve
January 29, 2026 - - Latest News -
How an Australian Campaign Is tackling the silent epidemic of heart and kidney disease
January 29, 2026 - - Latest News -
ARCS warns workforce gaps threaten returns on clinical trials reform
January 29, 2026 - - Latest News -
AstraZeneca appoints new country president as Ben McDonald transitions to global role
January 29, 2026 - - Latest News -
Why do some appear so uncomfortable with this group of people getting help?
January 29, 2026 - - Latest News -
New digital health reforms to give Australians a more complete medicines history
January 28, 2026 - - Latest News -
Peer-reviewed validation strengthens Paradigm’s osteoarthritis program
January 28, 2026 - - Australian Biotech

